- Home
- TRMK vs HCM Comparison
TRMK vs HCM Comparison
Compare TRMK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- HCM
- Stock Information
- Founded
- TRMK 1889
- HCM 2000
- Country
- TRMK United States
- HCM Hong Kong
- Employees
- TRMK N/A
- HCM N/A
- Industry
- TRMK Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- TRMK Finance
- HCM Health Care
- Exchange
- TRMK Nasdaq
- HCM Nasdaq
- Market Cap
- TRMK 2.2B
- HCM 2.5B
- IPO Year
- TRMK 1987
- HCM N/A
- Fundamental
- Price
- TRMK $38.74
- HCM $17.69
- Analyst Decision
- TRMK Buy
- HCM Buy
- Analyst Count
- TRMK 4
- HCM 2
- Target Price
- TRMK $40.50
- HCM $23.50
- AVG Volume (30 Days)
- TRMK 341.7K
- HCM 60.7K
- Earning Date
- TRMK 07-22-2025
- HCM 08-07-2025
- Dividend Yield
- TRMK 2.48%
- HCM N/A
- EPS Growth
- TRMK 50.91
- HCM N/A
- EPS
- TRMK 3.85
- HCM 0.04
- Revenue
- TRMK $544,423,000.00
- HCM $630,201,000.00
- Revenue This Year
- TRMK $57.30
- HCM $14.86
- Revenue Next Year
- TRMK $3.88
- HCM $19.54
- P/E Ratio
- TRMK $10.07
- HCM $77.78
- Revenue Growth
- TRMK N/A
- HCM N/A
- 52 Week Low
- TRMK $29.77
- HCM $11.51
- 52 Week High
- TRMK $40.73
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- TRMK 61.72
- HCM 69.39
- Support Level
- TRMK $36.82
- HCM $15.95
- Resistance Level
- TRMK $39.21
- HCM $17.97
- Average True Range (ATR)
- TRMK 1.03
- HCM 0.30
- MACD
- TRMK -0.05
- HCM 0.17
- Stochastic Oscillator
- TRMK 74.00
- HCM 91.02
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.